Atsena Therapeutics

Atsena Therapeutics, Inc. is a biotechnology company focused on developing gene therapies for inherited retinal diseases. They aim to restore or preserve vision in patients with these conditions by using innovative adeno-associated virus (AAV) technology to deliver therapeutic genes to the retina. Atsena generates revenue through partnerships, collaborations, and potentially future product sales, as their therapies progress through clinical trials. Founded in 2019 and based in North Carolina, the company is driven by a team of experts in ophthalmology and gene therapy, with a mission to address unmet medical needs in ophthalmic care.

Recent Posts by Atsena Therapeutics

1-5 of 5